People · Operator
Named in public records as an officer, director or promoter · active 2011–2025 · Software / Tech, Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| JUUL Labs, Inc. | — | Software / Tech | Growth/Late | $4.4B | $31.4B | 2017 |
| Pliant Therapeutics, Inc. | — | Biotechnology | Series D+ | $162.6M | $4.1B | 2018 |
| Akari Therapeutics Plc | — | Biotechnology | Series C | $140.5M | $34.1M | 2025 |
| Rezolute, Inc. | — | Biotechnology | Series C | $85.0M | $1.5B | 2014 |
| Eidos Therapeutics, Inc. | — | Biotechnology | Series B | $26.0M | $1.0B | 2018 |
| Calibra Medical, Inc. | — | Other Health Care | Series A | $19.8M | $163.7M | 2011 |
| PolyRemedy Inc | — | Other Health Care | Series A | $13.7M | $10.9M | 2016 |
Hoyoung Huh at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Hoyoung Huh on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Wende Hutton | 1 | 16 |
| Michael Greeley | 1 | 15 |
| Annette Campbell-White | 1 | 11 |
| Richard Lin | 1 | 8 |
| Samir Patel | 1 | 7 |
| David Sidransky | 1 | 7 |
| Stephen Shapiro | 1 | 6 |
| James Hill | 1 | 6 |
| Dennis Condon | 1 | 5 |
| Riaz Valani | 1 | 5 |
| Kevin Barrett | 1 | 5 |
| Nathan Every | 1 | 5 |
| Douglas Roeder | 1 | 5 |
| MARK COHEN | 1 | 5 |
| Jeffrey Jones | 1 | 5 |
| NEIL EXTER | 1 | 5 |
| Yuval Cohen | 1 | 4 |
| Wendy DiCicco | 1 | 4 |
| Kevin Connors | 1 | 4 |
| Kevin Burns | 1 | 4 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.